Search research articles
Contact Us
Filters
Showing results (101-110 of 130) with videos related to
Page
of 13
Sort By:
Pathology
|
August 28, 2022
Novel modes of MPL activation in triple-negative myeloproliferative neoplasms
Saumya E Samaraweera, Tatjana Geukens, Debora A Casolari, et al.
Immunological Reviews
|
January 3, 2025
The β Common Cytokine Receptor Family Reveals New Functional Paradigms From Structural Complexities
Winnie L Kan, Claire M Weekley, Tracy L Nero, et al.
Leukemia
|
October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells
David M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.
Hemasphere
|
March 25, 2025
Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey
Claire N Harrison, David M Ross, Laura Maria Fogliatto, et al.
British Journal of Haematology
|
December 23, 2025
The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemia
David T Yeung, Andrew P Grigg, John Reynolds, et al.
Hemasphere
|
February 16, 2026
Deep cytomorphology identifies erythroid skewing and monocytic morphology to predict TKI sensitivity in CML patients
Katariina Luukkainen, Mikko Purhonen, Mikael Tatun, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 4, 2024
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies
Stacie Hudgens, Srdan Verstovsek, Lysbeth Floden, et al.
Hemasphere
|
October 30, 2023
Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study
Ruben A Mesa, Claire Harrison, Jeanne M Palmer, et al.
Cancer Medicine
|
April 6, 2023
Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies
Ruben A Mesa, Stacie Hudgens, Lysbeth Floden, et al.
Blood Advances
|
February 27, 2026
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemia
Harinder Gill, Francesca Palandri, David M Ross, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 130) with videos related to
Sort By:
Page
of 13
Pathology
|
August 28, 2022
Novel modes of MPL activation in triple-negative myeloproliferative neoplasms
Saumya E Samaraweera, Tatjana Geukens, Debora A Casolari, et al.
Immunological Reviews
|
January 3, 2025
The β Common Cytokine Receptor Family Reveals New Functional Paradigms From Structural Complexities
Winnie L Kan, Claire M Weekley, Tracy L Nero, et al.
Leukemia
|
October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells
David M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.
Hemasphere
|
March 25, 2025
Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey
Claire N Harrison, David M Ross, Laura Maria Fogliatto, et al.
British Journal of Haematology
|
December 23, 2025
The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemia
David T Yeung, Andrew P Grigg, John Reynolds, et al.
Hemasphere
|
February 16, 2026
Deep cytomorphology identifies erythroid skewing and monocytic morphology to predict TKI sensitivity in CML patients
Katariina Luukkainen, Mikko Purhonen, Mikael Tatun, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 4, 2024
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies
Stacie Hudgens, Srdan Verstovsek, Lysbeth Floden, et al.
Hemasphere
|
October 30, 2023
Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study
Ruben A Mesa, Claire Harrison, Jeanne M Palmer, et al.
Cancer Medicine
|
April 6, 2023
Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies
Ruben A Mesa, Stacie Hudgens, Lysbeth Floden, et al.
Blood Advances
|
February 27, 2026
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemia
Harinder Gill, Francesca Palandri, David M Ross, et al.
Page
of 13